09/03/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 4:06 PM | GORDON CARL L (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:01 PM | Keros Therapeutics (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:12 PM | Keros Therapeutics (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 3:02 PM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 4:15 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
|
06/17/2024 4:17 PM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 5:07 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 3:10 PM | BIENAIME JEAN JACQUES (Reporting) Keros Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/05/2024 3:11 PM | BIENAIME JEAN JACQUES (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2024 3:15 PM | Farzan Nima (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | GORDON CARL L (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | GRAY MARY ANN (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Keros Therapeutics (Issuer) Knowles Julius (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Keros Therapeutics (Issuer) Nussbaum Ran (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Kariv Tomer (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Keros Therapeutics (Issuer) Seth Alpna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 7:03 AM | Keros Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024 7:00 AM | Keros Therapeutics (Filer)
| Form S-3ASR | |
03/14/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 7:02 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 3:02 PM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 7:37 PM | Cooper Simon Peter (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:38 PM | Keros Therapeutics (Issuer) Rovaldi Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:40 PM | Keros Therapeutics (Issuer) Regnante Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:41 PM | Keros Therapeutics (Issuer) Seehra Jasbir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:38 PM | ALKEON CAPITAL MANAGEMENT LLC (Filed by) Keros Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:16 AM | FMR LLC (Filed by) Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024 4:26 PM | BlackRock Inc. (Filed by) Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 3:43 PM | Keros Therapeutics (Issuer) Regnante Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:02 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
01/04/2024 3:04 PM | Keros Therapeutics (Subject) Regnante Keith (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 3:04 PM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 7:04 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Say Goodbye to the US Dollar (Ad) The warning signs are everywhere…
According to experts, the United States Dollar is "as good as doomed."
I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9226&Placement=NativeDisplay&Source=NativeDisplay) [RUSH MY FREE GUIDE] |
12/13/2023 4:20 PM | Keros Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/11/2023 5:44 PM | Keros Therapeutics (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 5:02 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 7:06 AM | Keros Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 7:11 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |